HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

p190RhoGAP mediates protective effects of oxidized phospholipids in the models of ventilator-induced lung injury.

Abstract
Products resulting from oxidation of cell membrane phospholipid 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine (OxPAPC) exhibit potent protective effects against lung endothelial cell (EC) barrier dysfunction caused by pathologically relevant mechanical forces and inflammatory agents. These effects were linked to enhancement of peripheral cytoskeleton and cell adhesion interactions mediated by small GTPase Rac and inhibition of Rho-mediated barrier-disruptive signaling. However, the mechanism of OxPAPC-induced, Rac-dependent Rho downregulation critical for vascular barrier protection remains unclear. This study tested the hypothesis that Rho negative regulator p190RhoGAP is essential for OxPAPC-induced lung barrier protection against ventilator-induced lung injury (VILI), and investigated potential mechanism of p190RhoGAP targeting to adherens junctions (AJ) via p120-catenin. OxPAPC induced peripheral translocation of p190RhoGAP, which was abolished by knockdown of Rac-specific guanine nucleotide exchange factors Tiam1 and Vav2. OxPAPC also induced Rac-dependent tyrosine phosphorylation and association of p190RhoGAP with AJ protein p120-catenin. siRNA-induced knockdown of p190RhoGAP attenuated protective effects of OxPAPC against EC barrier compromise induced by thrombin and pathologically relevant cyclic stretch (18% CS). In vivo, p190RhoGAP knockdown significantly attenuated protective effects of OxPAPC against ventilator-induced lung vascular leak, as detected by increased cell count and protein content in the bronchoalveolar lavage fluid, and tissue neutrophil accumulation in the lung. These results demonstrate for the first time a key role of p190RhoGAP for the vascular endothelial barrier protection in VILI.
AuthorsAnna A Birukova, Noureddine Zebda, Ivan Cokic, Panfeng Fu, Tinghuai Wu, Oleksii Dubrovskyi, Konstantin G Birukov
JournalExperimental cell research (Exp Cell Res) Vol. 317 Issue 6 Pg. 859-72 (Apr 01 2011) ISSN: 1090-2422 [Electronic] United States
PMID21111731 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2010 Elsevier Inc. All rights reserved.
Chemical References
  • 1-palmitoyl-2-arachidonyl-3-phosphorylcholine
  • ARHGAP35 protein, human
  • Guanine Nucleotide Exchange Factors
  • Phosphatidylcholines
  • Phospholipids
  • Repressor Proteins
Topics
  • Animals
  • Disease Models, Animal
  • Endothelial Cells (drug effects, metabolism, physiology)
  • Gene Expression Regulation (drug effects)
  • Gene Knockdown Techniques
  • Guanine Nucleotide Exchange Factors (genetics, metabolism)
  • Humans
  • Mice
  • Oxidation-Reduction
  • Phosphatidylcholines (pharmacology)
  • Phospholipids (metabolism)
  • Repressor Proteins (genetics, metabolism)
  • Ventilator-Induced Lung Injury (physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: